H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Census population 301,578. Missouri Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed St. Louis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a St. Louis storefront.
Orthobiologic Treatments for Your Practice in St. Louis, MO for clinics & physicians. Premium orthobiologi… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Missouri chart is a denial pattern. You are J5. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Use Missouri Department of Health & Senior Services for community education; use the IFU for the product in the fridge. orthobiologic treatments is the SKU conversation, not a patient appointment book.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)Missouri shares J5 with IA, KS, NE. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a St. Louis trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 13.2% of adults — 1.2 points above the U.S. 12% figure. Obesity is 36.8%; arthritis is 24.2%. That is place-level BRFSS modeling, not a clinic census and not a St. Louis trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. WPS Government Health Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Missouri.
Bring specialty, monthly joint / regenerative volume, and whether you bill J5 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.2% diabetes and 24.2% arthritis for St. Louis — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in St. Louis, MO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for St. Louis is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for St. Louis — 1.2 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Missouri Part B wound biologics follow this contractor (siblings: IA, KS, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in St. Louis. Useful for joint-program math; still needs a diagnosis and privileging.
No St. Louis storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.